Clinical Impact of GATA2 Mutations in Acute Myeloid Leukemia Patients Harboring CEBPA Mutations: A Study of the AM L Study Group (AMLSG)

被引：5
|
作者：
Theis, Frauke
Corbacioglu, Andrea
Gaidzik, Verena I.
Paschka, Peter
Spaeth, Daniela
Rehrl, Michaela
Bullinger, Lars
Schlegelberger, Brigitte
Goehring, Gudrun
Koehne, Claus-Henning
Germing, Ulrich
Brossart, Peter
Horst, Heinz-August
Haase, Detlef
Goetze, Katharina S.
Ringhoffer, Mark
Fiedler, Walter
Nachbaur, David
Kindler, Thomas
Held, Gerhard
Krauter, Juergen
Heuser, Michael
Ganser, Arnold
Doehner, Hartmut
Schlenk, Richard F.
Doehner, Konstanze
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1332.1332
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1332
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group
    Matsuo, H.
    Kajihara, M.
    Tomizawa, D.
    Watanabe, T.
    Saito, A. M.
    Fujimoto, J.
    Horibe, K.
    Kodama, K.
    Tokumasu, M.
    Itoh, H.
    Nakayama, H.
    Kinoshita, A.
    Taga, T.
    Tawa, A.
    Taki, T.
    Tanaka, S.
    Adachi, S.
    BLOOD CANCER JOURNAL, 2014, 4 : e226 - e226
  • [42] A Comparison of Two Methods for Screening CEBPA Mutations in Patients with Acute Myeloid Leukemia
    Ahn, Jeung-Yeal
    Seo, Katie
    Weinberg, Olga
    Boyd, Scott D.
    Arber, Daniel A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (04): : 319 - 323
  • [43] Novel Mutations in CEBPA in Korean Patients with Acute Myeloid Leukemia with a Normal Karyotype
    Kim, Sollip
    Kim, Dong-Hwan
    Jang, Jun-Ho
    Jung, Chul-Won
    Jang, Mi-Ae
    Ki, Chang-Seok
    Kim, Jong-Won
    Kim, Sun-Hee
    Kim, Hee-Jin
    ANNALS OF LABORATORY MEDICINE, 2012, 32 (02) : 153 - 157
  • [44] GENETIC CHARACTERIZATION OF A LARGE GROUP OF CEBPA MUTATED AML PATIENTS AND THE EFFECT OF TET2 AND GATA2 MUTATIONS ON OUTCOME
    Konstandin, N. P.
    Pastore, F.
    Dufour, A.
    Metzeler, K. H.
    Rothenberg-Thurley, M.
    Herold, T.
    Schneider, S.
    Ksienzyk, B.
    Tschuri, S.
    Berdel, W. E.
    Woermann, B. J.
    Sauerland, C.
    Braess, J.
    Stefan, B. K.
    Hiddemann, W.
    Spiekermann, K.
    HAEMATOLOGICA, 2017, 102 : 363 - 364
  • [45] GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
    Tien, Feng-Ming
    Hou, Hsin-An
    Tsai, Cheng-Hong
    Tang, Jih-Luh
    Chiu, Yu-Chiao
    Chen, Chien-Yuan
    Kuo, Yuan-Yeh
    Tseng, Mei-Hsuan
    Peng, Yen-Ling
    Liu, Ming-Chih
    Liu, Chia-Wen
    Liao, Xiu-Wen
    Lin, Liang-In
    Lin, Chien-Ting
    Wu, Shang-Ju
    Ko, Bor-Sheng
    Hsu, Szu-Chun
    Huang, Shang-Yi
    Yao, Ming
    Chou, Wen-Chien
    Tien, Hwei-Fang
    BLOOD CANCER JOURNAL, 2018, 8
  • [46] High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia
    Pasquet, Marlene
    Bellanne-Chantelot, Christine
    Tavitian, Suzanne
    Prade, Nais
    Beaupain, Blandine
    LaRochelle, Olivier
    Petit, Arnaud
    Rohrlich, Pierre
    Ferrand, Christophe
    Van den Neste, Eric
    Poirel, Helene A.
    Lamy, Thierry
    Ouachee-Chardin, Marie
    Mansat-De Mas, Veronique
    Corre, Jill
    Recher, Christian
    Plat, Genevieve
    Bachelerie, Francoise
    Donadieu, Jean
    Delabesse, Eric
    BLOOD, 2013, 121 (05) : 822 - 829
  • [47] RUNX1 MUTATIONS FORM A DISTINCT MOLECULAR SUBGROUP IN ACUTE MYELOID LEUKEMIA: RESULTS OF THE AML STUDY GROUP (AMLSG)
    Gaidzik, V.
    Bullinger, L.
    Schlenk, R.
    Zimmermann, A.
    Roeck, J.
    Schlegelberger, B.
    Krauter, J.
    Ganser, A.
    Spaeth, D.
    Doehner, H.
    Doehner, K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 483 - 483
  • [48] GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
    Feng-Ming Tien
    Hsin-An Hou
    Cheng-Hong Tsai
    Jih-Luh Tang
    Yu-Chiao Chiu
    Chien-Yuan Chen
    Yuan-Yeh Kuo
    Mei-Hsuan Tseng
    Yen-Ling Peng
    Ming-Chih Liu
    Chia-Wen Liu
    Xiu-Wen Liao
    Liang-In Lin
    Chien-Ting Lin
    Shang-Ju Wu
    Bor-Sheng Ko
    Szu-Chun Hsu
    Shang-Yi Huang
    Ming Yao
    Wen-Chien Chou
    Hwei-Fang Tien
    Blood Cancer Journal, 8
  • [49] TET2 Mutations In Acute Myeloid Leukemia (AML): Results on 783 Patients Treated within the AML HD98A Study of the AML Study Group (AMLSG)
    Gaidzik, Verena I.
    Schlenk, Richard F.
    Paschka, Peter
    Koehne, Claus-Henning
    Held, Gerhard
    Habdank, Marianne
    Gohlke, Juliane
    Mergenthaler, Hans-Guenther
    Salwender, Hans J.
    Bullinger, Lars
    Doehner, Hartmut
    Doehner, Konstanze
    BLOOD, 2010, 116 (21) : 48 - 48
  • [50] DNMT3A MUTATIONS IN ACUTE MYELOID LEUKEMIA (AML): MONITORING OF MINIMAL RESIDUAL DISEASE (MRD). A STUDY OF THE AML STUDY GROUP (AMLSG)
    Gaidzik, V. I.
    Weber, D.
    Paschka, P.
    Krieger, S.
    Kaumanns, A.
    Kroenke, J.
    Kapp-Schwoerer, S.
    Koehne, C. -H.
    Horst, H. -A.
    Schmidt-Wolf, I.
    Held, G.
    Kuendgen, A.
    Ringhoffer, M.
    Goetze, K.
    Kindler, T.
    Fiedler, W.
    Wattad, M.
    Corbacioglu, A.
    Bullinger, L.
    Schlegelberger, B.
    Thol, F.
    Heuser, M.
    Ganser, A.
    Schlenk, R. F.
    Doehner, H.
    Doehner, K.
    HAEMATOLOGICA, 2015, 100 : 163 - 163
12345